EGAS00001000089

Study Description

Cancer is driven by mutation. Illumina GA massively parallel sequencing technology will be applied to Agilent exome hybridisation capture... Show More

EGAS00001000089

Study Accession Alternative Stable ID type
EGAS00001000089 Other

Publications

21995386